Trial Profile
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Dectrekumab (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals Corporation
- 01 Jul 2014 New trial record